Efficacy and safety of adjuvant therapy with PD-1/PD-L1 inhibitors in cancer

Mo, DC; Liang, ZY; Chen, L; Huang, JF; Luo, PH; Wang, HL

Mo, DC (通讯作者)，Guangxi Med Univ, Affiliated Hosp 3, Radiotherapy Dept, 13 Dan Cun Rd, Nanning 530000, Guangxi, Peoples R China.

EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022; 24 (6):

Abstract

Anti-programmed cell death protein-1 (PD-1)/programmed cell death 1 ligand 1 (PD-L1) antibodies have been widely used in cancers. The present study ai......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索